secwatch.observer — SEC 8-K summary
======================================

Issuer:     HCW Biologics Inc. (HCWB)
CIK:        0001828673
Form:       8-K
Filed at:   2025-04-01T23:59:59+00:00
Accession:  0000950170-25-048619
Event type: other_material
Sentiment:  negative
Materiality: 0.60
Item codes: 3.03, 5.03, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

HCW Biologics approves 1-for-40 reverse stock split to regain Nasdaq compliance
-------------------------------------------------------------------------------

- Reverse split effective April 11, 2025; outstanding shares reduced from ~44.9M to ~1.12M.
- Purpose: raise bid price above $1.00 to regain compliance with Nasdaq Listing Rule 5810(c)(3)(A).
- Authorized shares remain 250M; no change to par value ($0.0001).
- Fractional shares rounded up; CUSIP changes to 40423R204.
- Stockholders approved at special meeting March 31, 2025; board acted same day.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1828673/000095017025048619/0000950170-25-048619-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1828673/000095017025048619/hcwb-20250401.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-048619

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer